XML 341 R109.htm IDEA: XBRL DOCUMENT
v3.23.1

Business Segments (Revenue by Product) (Details) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2021
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | $ 1,127,725 | $ 1,086,812 | $ 943,365
Analgesics |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 119,262 | 119,323 | 119,142
Cough & Cold |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 126,988 | 107,080 | 70,641
Women's Health |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 251,351 | 264,509 | 268,097
Gastrointestinal |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 226,583 | 204,559 | 161,136
Eye & Ear Care |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 171,076 | 163,449 | 110,409
Dermatologicals |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 123,741 | 120,386 | 107,083
Oral Care |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 97,627 | 97,521 | 101,431
Other OTC |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 11,097 | 9,985 | 5,426
North American OTC Healthcare |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 973,774 | 967,881 | 849,319
North American OTC Healthcare | Analgesics |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 116,582 | 117,868 | 117,775
North American OTC Healthcare | Cough & Cold |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 100,218 | 86,855 | 56,158
North American OTC Healthcare | Women's Health |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 231,754 | 249,136 | 252,535
North American OTC Healthcare | Gastrointestinal |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 156,957 | 152,191 | 124,755
North American OTC Healthcare | Eye & Ear Care |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 151,879 | 149,454 | 99,774
North American OTC Healthcare | Dermatologicals |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 119,822 | 117,173 | 103,998
North American OTC Healthcare | Oral Care |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 85,542 | 85,239 | 88,903
North American OTC Healthcare | Other OTC |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 11,020 | 9,965 | 5,421
International OTC Healthcare |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 153,951 | 118,931 | 94,046
International OTC Healthcare | Analgesics |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 2,680 | 1,455 | 1,367
International OTC Healthcare | Cough & Cold |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 26,770 | 20,225 | 14,483
International OTC Healthcare | Women's Health |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 19,597 | 15,373 | 15,562
International OTC Healthcare | Gastrointestinal |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 69,626 | 52,368 | 36,381
International OTC Healthcare | Eye & Ear Care |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 19,197 | 13,995 | 10,635
International OTC Healthcare | Dermatologicals |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 3,919 | 3,213 | 3,085
International OTC Healthcare | Oral Care |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | 12,085 | 12,282 | 12,528
International OTC Healthcare | Other OTC |  |  |
Revenue from External Customer [Line Items] |  |  |
Total segment revenues | $ 77 | $ 20 | $ 5

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=pbh_AnalgesicsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pbh_CoughAndColdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pbh_WomensHealthMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pbh_GastrointestinalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pbh_EyeAndEarCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pbh_DermatologicalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pbh_OralCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pbh_OtherOtcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pbh_NorthAmericanOTCHealthcareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=pbh_InternationalOTCHealthcareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |